Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma

The Lancet Oncology

Volumn 10, Issue 4, 2009, Pages 409-416

  Guadagnolo, B Ashleigh ^a   Zagars, Gunar K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARM EDEMA; AXILLARY LYMPH NODE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DOSIMETRY; HUMAN; INGUINAL LYMPH NODE; LEG EDEMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MELANOMA; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE RISK; REVIEW;

CLINICAL TRIALS AS TOPIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 63149172139     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70043-9     Document Type: Review

References (55)

1. Markovic S.N., Erickson L.A., Rao R.D., et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 82 (2007) 364-380
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
3. Amersi F., and Morton D.L. The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 41 (2007) 241-256
4. McMasters K.M., Wong S.L., Edwards M.J., et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 130 (2001) 151-156
5. Mendenhall W.M., Amdur R.J., Grobmyer S.R., et al. Adjuvant radiotherapy for cutaneous melanoma. Cancer 112 (2008) 1189-1196
6. Ballo M.T., and Ang K.K. Radiotherapy for cutaneous malignant melanoma: rationale and indications. Oncology 18 (2004) 99-107
7. Berk L.B. Radiation therapy as primary and adjuvant treatment for local and regional melanoma. Cancer Control 15 (2008) 233-238
8. Mack L.A., and McKinnon J.G. Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 86 (2004) 189-199
9. Shen P., Wanek L.A., and Morton D.L. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?. Ann Surg Oncol 7 (2000) 554-559
10. Ridge J.A. Adjuvant radiation after lymph node dissection for melanoma. Ann Surg Oncol 7 (2000) 550-551
11. Fuhrmann D., Lippold A., Borrosch F., Ellwanger U., Garbe C., and Suter L. Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?. Br J Dermatol 144 (2001) 66-70
12. Calabro A., Singletary S.E., and Balch C.M. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124 (1989) 1051-1055
13. Lee R.J., Gibbs J.F., Proulx G.M., Kollmorgen D.R., Jia C., and Kraybill W.G. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 46 (2000) 467-474
14. Miller E.J., Daly J.M., Synnestvedt M., Schultz D., Elder D., and Guerry D. Loco-regional nodal relapse in melanoma. Surg Oncol 1 (1992) 333-340
15. Kretschmer L., Neumann C., Preusser K.P., and Marsch W.C. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin-an analysis of survival and local recurrence. Acta Oncol 40 (2001) 72-78
16. Bowsher W.G., Taylor B.A., and Hughes L.E. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 73 (1986) 906-908
17. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual. Sixth edn (2002), Springer, New York
18. Burmeister B.H., Smithers B.M., Poulsen M., et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 19 (1995) 369-371
19. Corry J., Smith J.G., Bishop M., and Ainslie J. Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 44 (1999) 1065-1069
20. Cooper J.S., Chang W.S., Oratz R., Shapiro R.L., and Roses D.F. Elective radiation therapy for high-risk malignant melanomas. Cancer J 7 (2001) 498-502
21. Morris K.T., Marquez C.M., Holland J.M., and Vetto J.T. Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol 7 (2000) 680-684
22. Ballo M.T., Ross M.I., Cormier J.N., et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 64 (2006) 106-113
23. Burmeister B.H., Mark Smithers B., Burmeister E., et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 81 (2006) 136-142
24. Creagan E.T., Cupps R.E., Ivins J.C., et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study. Cancer 42 (1978) 2206-2210
25. Byers R.M. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 121 (1986) 1338-1341
26. O'Brien C.J., Coates A.S., Petersen-Schaefer K., et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162 (1991) 310-314
27. Pidhorecky I., Lee R.J., Proulx G., et al. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol 8 (2001) 109-115
28. O'Brien C.J., Petersen-Schaefer K., Stevens G.N., et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 19 (1997) 589-594
29. Moncrieff M.D., Martin R., O'Brien C.J., et al. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?. Ann Surg Oncol 15 (2008) 3022-3027
30. Ballo M.T., Garden A.S., Myers J.N., et al. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?. Head Neck 27 (2005) 718-721
31. Bonnen M.D., Ballo M.T., Myers J.N., et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 100 (2004) 383-389
32. Ballo M.T., Bonnen M.D., Garden A.S., et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97 (2003) 1789-1796
33. Karakousis C.P., Hena M.A., Emrich L.J., and Driscoll D.L. Axillary node dissection in malignant melanoma: results and complications. Surgery 108 (1990) 10-17
34. Beadle B.M., Guadagnolo B.A., Ballo M.T., et al. Radiation Therapy Field Extent for Adjuvant Treatment of Axillary Metastases from Malignant Melanoma. Int J Radiat Oncol Biol Phys (2008) 10.1016/j.ijrobp.2008.06.1910 published online Sept 5.
35. Kretschmer L., and Preusser K.P. Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma. Langenbecks Arch Surg 386 (2001) 418-425
36. Burmeister B.H., Smithers B.M., Davis S., et al. Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J Surg 72 (2002) 344-348
37. Stevens G., Thompson J.F., Firth I., O'Brien C.J., McCarthy W.H., and Quinn M.J. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 88 (2000) 88-94
38. Starritt E.C., Joseph D., McKinnon J.G., Lo S.K., de Wilt J.H., and Thompson J.F. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg 240 (2004) 866-874
39. Gadd M.A., and Coit D.G. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 127 (1992) 1412-1416
40. Hughes T.M., A'Hern R.P., and Thomas J.M. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 87 (2000) 892-901
41. Ballo M.T., Zagars G.K., Gershenwald J.E., et al. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol 11 (2004) 1079-1084
42. Allan C.P., Hayes A.J., and Thomas J.M. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. ANZ J Surg 78 (2008) 982-986
43. Karakousis C.P., Driscoll D.L., Rose B., and Walsh D.L. Groin dissection in malignant melanoma. Ann Surg Oncol 1 (1994) 271-277
44. Strobbe L.J., Jonk A., Hart A.A., Nieweg O.E., and Kroon B.B. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 6 3 (1999) 255-262
45. Urist M.M., Maddox W.A., Kennedy J.E., and Balch C.M. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 51 (1983) 2152-2156
46. Rofstad E.K. Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma. Cancer Res 52 (1992) 4453-4457
47. Rofstad E.K. Fractionation sensitivity (alpha/beta ratio) of human melanoma xenografts. Radiother Oncol 33 (1994) 133-138
48. Stevens G., and McKay M.J. Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol 7 (2006) 575-583
49. Overgaard J., Overgaard M., Hansen P.V., and von der Maase H. Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 5 (1986) 183-192
50. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 12 (1986) 867-872
51. Bentzen S.M., Overgaard J., Thames H.D., et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 16 (1989) 169-182
52. Sause W.T., Cooper J.S., Rush S., et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20 (1991) 429-432
53. Overgaard J., von der Maase H., and Overgaard M. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. Int J Radiat Oncol Biol Phys 11 (1985) 1837-1839
54. Ang K.K., Byers R.M., Peters L.J., et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg 116 (1990) 169-172
55. Ang K.K., Peters L.J., Weber R.S., et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 30 (1994) 795-798